Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one

Bibliographic Details
Main Authors:	Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Revista Portuguesa de Cardiologia
Online Access:	http://www.sciencedirect.com/science/article/pii/S0870255123004602

Internet